# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Adrenocortical Carcinoma

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 21 results.
Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy Lines
Status: Recruiting
Last Changed: Apr 11, 2018
First Received: Aug 22, 2017
Disease(s): Adrenocortical Carcinoma
Intervention(s): Cabazitaxel
Locations: Azienda Ospedaliera Spedali Civili di Brescia, Brescia, Italy
Cabozantinib in Advanced Adrenocortical Carcinoma
Status: Recruiting
Last Changed: Aug 05, 2019
First Received: Aug 02, 2018
Disease(s): Adrenocortical Carcinoma
Intervention(s): Cabozantinib-s-malate
Locations: University Hospital Würzburg, Würzburg, Germany
Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma
Status: Recruiting
Last Changed: Oct 30, 2018
First Received: Oct 30, 2018
Disease(s): Adrenocortical Carcinoma
Intervention(s): Cisplatin plus Etoposide, Observation or Mitotane
Locations: ASST Spedali Civili di Brescia, Brescia, BS, Italy
German Adrenocortical Carcinoma Registry
Status: Recruiting
Last Changed: Aug 28, 2018
First Received: Mar 29, 2007
Disease(s): Adrenocortical Carcinoma
Locations: University of Wuerzburg, Wuerzburg, Germany
Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
Status: Recruiting
Last Changed: Aug 06, 2019
First Received: Apr 25, 2017
Disease(s): Adrenocortical Carcinoma, Peritoneal Carcinomatosis
Intervention(s): Cisplatin, Sodium thiosulfate, Cytoreductive surgery
Locations: Columbia University Medical Center, New York, New York, United States
Efficacy of Adjuvant Mitotane Treatment (ADIUVO)
Status: Recruiting
Last Changed: May 08, 2017
First Received: Oct 22, 2008
Disease(s): Adrenocortical Carcinoma
Intervention(s): MITOTANE
Locations: Medical Oncology Branch - Center for Cancer Research - National Cancer Institute, Bethesda, Maryland, United States
Endocrine Oncology - University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
Endocrinologie - Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada
Endocrinologie - CHU Besançon Hôpital Jean Minjoz, Besancon, France
Endocrinologie - CHU Lyon Hôpital Pierre Wertheimer, Bron, France
... and 24 other locations.
Evaluation of Side Effects of Mitotane
Status: Recruiting
Last Changed: Aug 28, 2018
First Received: Dec 05, 2007
Disease(s): Adrenocortical Carcinoma
Locations: University Hospital, Wuerzburg, Germany
Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma
Status: Recruiting
Last Changed: May 22, 2019
First Received: Dec 12, 2017
Disease(s): Metastatic Carcinoma in the Adrenal Cortex, Stage III Adrenal Cortex Carcinoma AJCC v8, Stage IV Adrenal Cortex Carcinoma AJCC v8, Unresectable Adrenal Cortex Carcinoma
Intervention(s): Cabozantinib, Pharmacogenomic Study, Pharmacokinetic Study
Locations: M D Anderson Cancer Center, Houston, Texas, United States
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Participants With Stage I-III Adrenocortical Cancer With High Risk of Recurrence (ADIUVO-2)
Status: Recruiting
Last Changed: Sep 16, 2019
First Received: Jul 11, 2018
Disease(s): ENSAT Stage I Adrenal Cortex Carcinoma, ENSAT Stage II Adrenal Cortex Carcinoma, ENSAT Stage III Adrenal Cortex Carcinoma
Intervention(s): Cisplatin, Etoposide, Mitotane, Quality-of-Life Assessment
Locations: M D Anderson Cancer Center, Houston, Texas, United States
Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield
Status: Recruiting
Last Changed: Jun 10, 2019
First Received: Dec 24, 2014
Disease(s): Adrenal Incidentaloma, Adrenocortical Carcinoma
Locations: University Medical Center Groningen, Groningen, Netherlands